Evaluation of Different Dyspnea Scales in Smokers with Preserved FEV1/FVC Ratio

ORIGINAL ARTICLE
Besim Morina, Blerina Dervisholli, Mark Ross, Burim Neziri

 
For citation: Morina B, Dervisholli B, Ross M, Neziri B. Evaluation of Different Dyspnea Scales in Smokers with Preserved FEV1/FVC Ratio. International Journal of Biomedicine. 2025;15(1):72-77. doi:10.21103/Article15(1)_OA3
 
Originally published March 5, 2025

Abstract: 

Background: This study evaluated the relationships between two dyspnea scales (Modified Borg Scale [MBS] and modified Medical Research Council dyspnea scale [mMRCds]) and clinical characteristics of smokers with preserved FEV1/FVC ratio. It also assessed their ability to differentiate symptomatic (CAT score ≥10) from asymptomatic smokers (CAT score <10).
Methods and Results: Sixty-one smokers (FEV1: 98.69±15.83% of predicted, age: 29–77 years) were included in this study. Dyspnea intensity was assessed using MBS and mMRCds, and correlations were examined between these scales and pulmonary function tests, quality of life (QoL) indices, and physical parameters. ROC analysis determined cutoff values for dyspnea scales.
MBS (1.29±1.16) and mMRCds (0.61±0.92) scores were higher in symptomatic smokers. Both scales significantly correlated with 6-minute walk distance (MBS: rs=-0.519; mMRCds: rs=-0.699; P<0.001 in both cases) and QoL measures (CAT, SGRQ). Spirometry parameters showed significant correlations with both scales. ROC analysis demonstrated strong discriminatory ability for both mMRCds and MBS between symptomatic and asymptomatic groups.
Conclusion: mMRCds and MBS effectively assess dyspnea in smokers with preserved FEV1/FVC ratio, correlating with clinical and functional outcomes and distinguishing between symptomatic and asymptomatic individuals.

Keywords: 
smoking • spirometry • dyspnea • exercise test • quality of life
References: 
  1. Laviolette L, Laveneziana P; ERS Research Seminar Faculty. Dyspnoea: a multidimensional and multidisciplinary approach. Eur Respir J. 2014 Jun;43(6):1750-62. doi: 10.1183/09031936.00092613. Epub 2014 Feb 13. PMID: 24525437.
  2. Ambrosino N, Scano G. Dyspnoea and its measurement. Breathe. 2004; 1(2):100–107. doi: 10.1183/18106838.0102.100
  3. Gigliotti F. Mechanisms of dyspnea in healthy subjects. Multidiscip Respir Med. 2010 Jun 30;5(3):195-201. doi: 10.1186/2049-6958-5-3-195. PMID: 22958405; PMCID: PMC3463042.
  4. Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, Calverley PM, Gift AG, Harver A, Lareau SC, Mahler DA, Meek PM, O'Donnell DE; American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012 Feb 15;185(4):435-52. doi: 10.1164/rccm.201111-2042ST. PMID: 22336677; PMCID: PMC5448624.
  5. Miravitlles M, Anzueto A, Legnani D, Forstmeier L, Fargel M. Patient's perception of exacerbations of COPD--the PERCEIVE study. Respir Med. 2007 Mar;101(3):453-60. doi: 10.1016/j.rmed.2006.07.010. Epub 2006 Aug 30. PMID: 16938447.
  6. Frownfelter D, Jennifer RP. Dyspnea: Measurement and Evaluation. Cardiopulm Phys Ther J. 1999;11(1):7–15.
  7. Al-Ashkar F, Mehra R, Mazzone PJ. Interpreting pulmonary function tests: recognize the pattern, and the diagnosis will follow. Cleve Clin J Med. 2003 Oct;70(10):866, 868, 871-3, passim. doi: 10.3949/ccjm.70.10.866. PMID: 14621232.
  8. Ries AL. Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspnea. Am J Med. 2006 Oct;119(10 Suppl 1):12-20. doi: 10.1016/j.amjmed.2006.08.003. PMID: 16996895.
  9. Agusti A, Vogelmeier CF. GOLD 2024: a brief overview of key changes. J Bras Pneumol. 2023 Dec 22;49(6):e20230369. doi: 10.36416/1806-3756/e20230369. PMID: 38126685; PMCID: PMC10760434.
  10. Johnson MJ, Close L, Gillon SC, Molassiotis A, Lee PH, Farquhar MC; Breathlessness Research Interest Group (BRIG). Use of the modified Borg scale and numerical rating scale to measure chronic breathlessness: a pooled data analysis. Eur Respir J. 2016 Jun;47(6):1861-4. doi: 10.1183/13993003.02089-2015. Epub 2016 Mar 17. PMID: 26989107.
  11. Perez T, Burgel PR, Paillasseur JL, Caillaud D, Deslée G, Chanez P, Roche N; INITIATIVES BPCO Scientific Committee. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015 Aug 18;10:1663-72. doi: 10.2147/COPD.S82408. PMID: 26316740; PMCID: PMC4547644.
  12. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999 Jul;54(7):581-6. doi: 10.1136/thx.54.7.581. PMID: 10377201; PMCID: PMC1745516.
  13. Carter R, Holiday DB, Nwasuruba C, Stocks J, Grothues C, Tiep B. 6-minute walk work for assessment of functional capacity in patients with COPD. Chest. 2003 May;123(5):1408-15. doi: 10.1378/chest.123.5.1408. PMID: 12740255.
  14. Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, Arnold A, Newman AB; Cardiovascular Health Study. The 6-min walk test: a quick measure of functional status in elderly adults. Chest. 2003 Feb;123(2):387-98. doi: 10.1378/chest.123.2.387. PMID: 12576356.
  15. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009 Sep;34(3):648-54. doi: 10.1183/09031936.00102509. PMID: 19720809.
  16. Jones PW, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores. BMC Pulm Med. 2011 Aug 11;11:42. doi: 10.1186/1471-2466-11-42. PMID: 21835018; PMCID: PMC3199910.
  17. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med. 1991 Sep;85 Suppl B:25-31; discussion 33-7. doi: 10.1016/s0954-6111(06)80166-6. PMID: 1759018.
  18. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992 Jun;145(6):1321-7. doi: 10.1164/ajrccm/145.6.1321. PMID: 1595997.
  19. Ozalevli S, Ucan ES. The comparison of different dyspnoea scales in patients with COPD. J Eval Clin Pract. 2006 Oct;12(5):532-8. doi: 10.1111/j.1365-2753.2006.00658.x. PMID: 16987115.
  20. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest. 1999 Dec;116(6):1632-7. doi: 10.1378/chest.116.6.1632. PMID: 10593787.
  21. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988 Mar;93(3):580-6. doi: 10.1378/chest.93.3.580. PMID: 3342669.
  22. Guleria R, Behera D, Jindal SK. Correlation of lung function tests with dyspnoea scale, 12 minute walking test and visual analogue scale in patients with COPD. Indian J Chest Dis Allied Sci. 1989 Oct-Dec;31(4):241-5. PMID: 2638664.
  23. O'Donnell DE, Banzett RB, Carrieri-Kohlman V, Casaburi R, Davenport PW, Gandevia SC, Gelb AF, Mahler DA, Webb KA. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc. 2007 May;4(2):145-68. doi: 10.1513/pats.200611-159CC. PMID: 17494725.

Download Article
Received January 11, 2025.
Accepted February 22, 2025.
©2025 International Medical Research and Development Corporation.